IGG4-RELATED PLEURAL DISEASE: A CAUSE OF RECURRENT PLEURAL EFFUSION AFTER COVID-19 VACCINATION
Chest
; 162(4):A93-A94, 2022.
Article
in English
| EMBASE | ID: covidwho-2060539
antigen; endogenous compound; immunoglobulin G4; immunosuppressive agent; SARS-CoV-2 vaccine; steroid; adverse drug reaction; aged; antibody production; autoimmunity; cancer cell; cancer patient; cancer recurrence; case report; catheter; chronic obstructive lung disease; clinical article; complication; conference abstract; coronavirus disease 2019; corticosteroid therapy; decortication; diagnosis; drug therapy; dyspnea; early diagnosis; fibrosis; gene expression; hilar lymphadenopathy; histopathology; human; human cell; human tissue; immunoglobulin blood level; immunoglobulin G4 related disease; lung disease; lung parenchyma; lymphadenopathy; lymphocyte; lymphoid hyperplasia; male; molecular mimicry; multiple drug dose; nephritis; plasma cell; pleura biopsy; pleura disease; pleura effusion; pleura fluid; pleura thickening; pleurisy; pleurodesis; prostate cancer; sclerosis; side effect; surgery; T lymphocyte; Th2 cell; theoretical study; thoracoscopy; thorax; vaccination; x-ray computed tomography
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Chest
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS